There’s nothing more important to stock prices than earnings and expectations for earnings growth. Earnings, or net income, is literally the bottom line.While that’s a principle that plays out in the market in the long-run, it unfortunately isn’t promised in the short-run.Take this chart FactSet’s John Butters updates regularly. It shows the trajectory of the S&P 500 with the trajectory […]
Healthcare Highlights From Thursday 5/14 Game PlanEach week at ChartSmarter we like to bring to a little insight into what we do on a daily basis. We have been at it for 5 years and we love doing it. Each night we detail 7 to 8 of our favorite ideas, both long and short, for the next days session. We […]
Sam Ro
Jun. 1, 2015, 11:38 AM
739
There’s nothing more important to stock prices than earnings and expectations for earnings growth. Earnings, or net income, is literally the bottom line.While that’s a principle that plays out in the market in the long-run, it unfortunately doesn’t in the long run.Take this chart from FactSet’s John Butters. It shows the trajectory of the S&P […]
Twitter Stock Trading Stopped After Earnings LeakedApril 28, 2015Wall Street briefly halted trading for Twitter stock afternoon after the company’s Q1 earnings were leaked early. The leak appeared to come from Selerity, a data science company which is in the business of finding and reporting company earnings early. Selerity works to automatically identify the URL of a company’s earnings statement before […]
Related GPROGoPro: Market Expecting Nearly 9% Move Following EarningsEverything The Street Has Said About GoProTaser, Digital Ally Shares Up Amid Baltimore Clashes(Investor’s Business Daily)GoPro Inc (NASDAQ: GPRO) traders are scrambling to decide how to play the company’s earnings report coming after the market close. Fundamental and technical traders have likely been pouring over countless metrics for days trying to determine […]
View All3 Potent Biotech Stocks That Could Pop on EarningsLike golf, investing in biotech stocks can be cruel game. As Michael A. Gayed explains, the pricing dynamic of individual biotech stocks will often follow the perceived successes — or failures — of drug trials and the multiple approval procedures enforced by regulatory agencies.Source: ©iStock.com/twilightproductionsThis Wild West mentality is primarily the […]
It was a tumultuous week. Investors should get used to it because volatility is going to be with us for some time to come. You can blame a lot of things, but the evidence suggests that the dollar is the main culprit behind the market’s gyrations.The rate of ascent, rather than the direction of the dollar, is largely to blame […]
Akin Oyedele
Mar. 25, 2015, 5:45 PM
0
Screenshot via Bloomberg TVDavid RosenbergIt was a rough day for stocks.In a note to clients on Wednesday, Gluskin Sheff’s David Rosenberg took a step back to highlight four of the biggest obstacles facing the bull market.Here’s what Rosenberg outlined:Earnings momentum has slowed. Bottom-up consensus forecasts for S&P 500 operating earnings growth in the first quarter have […]
Update 1/27 After the Close Amgen Beats
Amgen, Inc (AMGN) fourth quarter earnings and sales beat estimates on strong sales of Enbrel, an arthritis drug.Revenue for Q4 was $5,33B a 6% increase over Q4 2013, The stock was up slightly after hours to $159.40. Sales growth was also driven by Kyprolis and Prolia. The P/S is still a modest 6.12 and […]
3 gifts for market bull
Discussing market volatility and the earnings picture for 2015, with Steve Auth, Federated Investors, and James Liu, JPMorgan Funds
With the U.S. stock market in an extended funk, earnings offer at least a temporary escape route.”The earnings season represents the first potential stop in this downward trend,” said Robert Pavlik, chief market strategist at Boston Private Wealth.Recent […]
